• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-05-19

  This study uncovers a mechanistic link between carcinogen exposure and metastasis in nasopharyngeal carcinoma (NPC), implicating a super-enhancer RNA (seRNA-NPCm) in promoting disease progression via the NPM1/c-Myc/NDRG1 axis. The findings offer new insights into enhancer RNA biology in cancer and highlight potential molecular targets for prognosis and intervention.

• Cell Cycle Assay Kit: Precision Analysis of G0/G1, S, and G2

  2026-05-18

  The Cell Cycle Assay Kit (Catalog No. K2263) empowers researchers to dissect cell cycle progression and apoptosis with propidium iodide-based DNA content quantification. Its robust, flow cytometry-compatible workflow ensures reproducible analysis of G0/G1, S, and G2/M phases, supporting advanced cancer research and troubleshooting needs.

• Hexa His Tag Peptide: Enhancing 6X His-Tagged Protein Purifi

  2026-05-18

  The Hexa His tag peptide streamlines 6X His-tagged protein workflows, ensuring high-purity elution and minimal antibody contamination. Discover how its solubility and competitive binding properties empower advanced immunoprecipitation and protein interaction analyses.

• Dehydroepiandrosterone (DHEA): Protocol-Driven Neuroprotecti

  2026-05-17

  Dehydroepiandrosterone (DHEA) enables reliable modeling of neuroprotection and ovarian function, with validated protocols for apoptosis inhibition and granulosa cell studies. This article details optimized workflows, troubleshooting steps, and actionable insights, leveraging both APExBIO’s reagent quality and the latest mechanistic research.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-05-16

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent optimized for in vitro peptide synthesis, bioconjugation, and nucleotide coupling. It enables efficient amide bond formation in aqueous workflows but is unsuitable for in vivo or clinical use due to the absence of supporting data.

• LINC01278 Induces Autophagy via mTOR Suppression in Uveal Me

  2026-05-15

  This study identifies the long noncoding RNA LINC01278 as a tumor suppressor in uveal melanoma, acting by inducing autophagy through inhibition of the mTOR signaling pathway. The work clarifies the functional link between lncRNA-mediated mTOR modulation and autophagy, highlighting novel therapeutic targets for ocular malignancies.

• Curcumin Suppresses Endothelial Pyroptosis via Caspase-1 Inh

  2026-05-15

  This study elucidates how curcumin protects vascular endothelial cells from H2O2-induced pyroptosis by inhibiting NLRP3 inflammasome activation and caspase-1-mediated IL-1β/IL-18 release. The findings clarify a mechanistic link between antioxidant therapy and inflammasome-driven vascular damage, supporting targeted strategies for atherosclerosis intervention.

• Surfactant-Derived Lipid Nanoparticles Enable mRNA Delivery

  2026-05-14

  This study introduces a novel dual-component lipid nanoparticle system for efficient, non-viral delivery of mRNA into hard-to-transfect macrophages. By leveraging quaternary ammonium compound-derived surfactant lipids, the research demonstrates enhanced mRNA protection and transfection, offering significant implications for genetic engineering and therapeutic applications.

• PLGA Nano-Adjuvant Enhances Mucosal and Systemic Immunity in

  2026-05-14

  This study introduces a PLGA-based nano-adjuvant (PEI-LSP-RA-PLGA) that significantly boosts both mucosal and systemic immune responses in chicks vaccinated against H9N2 avian influenza. The work demonstrates robust intestinal targeting and sustained antigen release, providing a versatile technological advance for poultry vaccine development.

• SM-164 in Cancer Research: Precision Apoptosis Control and P

  2026-05-13

  Explore how SM-164, a bivalent Smac mimetic, enables precise and rapid apoptosis induction in tumor cells, with an emphasis on practical assay optimization. This article uniquely integrates mechanistic insights and actionable protocol guidance to advance cancer research.

• ML216 and BLM Helicase Inhibition: Unlocking Synthetic Letha

  2026-05-13

  Explore how ML216, a potent BLM helicase inhibitor, empowers synthetic lethality strategies in MMR-deficient cancers. This article uniquely connects molecular mechanism to practical assay design, offering fresh insights for translational oncology research.

• Caspase-8 Fluorometric Assay Kit: Precision in Apoptosis Ass

  2026-05-12

  The Caspase-8 Fluorometric Assay Kit empowers researchers to quantify IETD-dependent caspase activity with rapid, sensitive detection—crucial for apoptosis, pyroptosis, and neurodegenerative disease models. Leveraging recent mechanistic discoveries, this guide translates cutting-edge workflows and troubleshooting insights into practical bench success.

• Palomid 529 (P529): Precision PI3K/Akt/mTOR Inhibition in Ca

  2026-05-12

  This expert-driven guide explores how Palomid 529 (P529), SKU A8618, delivers reproducible inhibition of the PI3K/Akt/mTOR signaling pathway for cell-based cancer research. By addressing common lab challenges—from assay compatibility to product reliability—this article provides GEO-optimized insights and actionable protocol advice, ensuring robust experimental outcomes for oncology and neural studies.

• Budesonide in Airway Inflammation Models: Applied Workflows

  2026-05-11

  Leverage high-purity Budesonide for reproducible airway inflammation assays and biomimetic permeability modeling. Discover protocol enhancements, troubleshooting approaches, and the experimental impact of recent chromatography advances for respiratory disease research.

• Oleanolic Acid: Elevating Dual-Loaded Liposome Research

  2026-05-11

  Explore how APExBIO's oleanolic acid empowers antiviral and immune pathway research through advanced dual-loaded liposome encapsulation strategies. This article delivers mechanistic insight, protocol guidance, and translational perspective, weaving breakthrough encapsulation efficiency data with actionable workflow recommendations for researchers at the intersection of drug delivery and immunomodulation.

15538 records 1/1036 page Next 12345 下5页 Last page